VHL and neoplasm: Moreover, tumor growth from Vhl-KO MC38 tumors in mice receiving the αIFNAR1 antibody was even faster than that of control tumors, similar to VC MC38 tumors treated with the αIFNAR1 antibody (Figures 3D and 3E).